Activating Collaborative CIS Support Via Targeted Provider Mailing

Completed · Not applicable

Conditions studied: Precancerous Condition

In brief

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Key facts

Study ID

NCT00873288

Run by

Northwestern University

People needed

254

Starts

2006-10-01

Expected to finish

2008-11-01

Last updated by the study team

2023-03-21

Who can join

Age: 18 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• DISEASE CHARACTERISTICS:
• Received an abnormal Pap test result
• Scheduled for a colposcopy within 6 months of their Pap test at either the Erie Family Health Center or the Prentice Ambulatory Clinic
• PATIENT CHARACTERISTICS:
• Female
• Able to communicate in either English or Spanish
• Clinic staff will review patient charts to determine eligibility
• PRIOR CONCURRENT THERAPY:
• Not specified

You may not qualify if…

• <18 years
• unable to communicate in English or Spanish
• no address to which a letter can be mailed

Where it is running

• Robert H. Lurie Comprehensive Cancer Center at Northwestern University — Chicago, Illinois, United States
• Erie Family Health Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.